Replies to post #137997 on Innovation Pharmaceuticals Inc (IPIX)

[Waverunner1]

We really like what we see in Kevetrin. For ovarian cancer we look forward to initiating an advanced trial in the first half of 2016 under the Orphan Drug designation.

http://cellceutix.com/cellceutix-first-annual-shareholder-meeting-december-15-2015/